510(k) K232991

BT-1000 by Bistos Co., Ltd. — Product Code QGL

K232991 is an FDA 510(k) premarket notification submitted by Bistos Co., Ltd. for the device "BT-1000". The FDA issued a decision of Substantially Equivalent on Aug 28, 2024. The device falls under product code QGL (Transcutaneous Nerve Stimulator For Adhd), a Class II device regulated under 21 CFR 882.5898. Bistos Co., Ltd. has 10 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Aug 28, 2024
Date Received
Sep 22, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Transcutaneous Nerve Stimulator For Adhd
Device Class
Class II
Regulation Number
882.5898
Review Panel
NE
Submission Type
510(k)

A transcutaneous electrical nerve stimulator for Attention Deficit Hyperactivity Disorder (ADHD) is a prescription device that stimulates transcutaneously or percutaneously through electrodes placed on the forehead.

Need the full FDA record for Bistos Co., Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K232991. Report a data issue: hello@regdatalab.com.